Abstract View

Author(s): Dr. Majid S. Khan*1, Devendra Bagul2, Sakshi Bachhav3, Nishigandha Bagul4, Sumit Birari5, Siddharth Batole6, Dr. Avish Maru7

Email(s): 1mskhanpharmacy@gmail.com

Address:

    Loknete Dr. J. D. Pawar College of Pharmacy, Manur, Kalwan, Nashik, Maharashtra

Published In:   Volume - 4,      Issue - 6,     Year - 2025

DOI: https://doi.org/10.71431/IJRPAS.2025.4609  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Effervescent tablets containing ajwain and fennel have potential as a novel drug delivery system, offering convenience, efficacy, and palatability. These herbal ingredients possess digestive and carminative properties, making them suitable for treating hyperacidity. Hyperacidity, characterized by excessive stomach acid production (pH 1.5-3.5), can cause burning sensations and lead to conditions like GERD, peptic ulcers, and duodenal ulcers. Antacid formulations, such as those containing magnesium or aluminum hydroxides, can help control acidity. The optimized formulation consisted of Anhydrous citric acid, tartaric acid, Bicarbonate of soda, Washing soda, talc, and other ingredients, which demonstrated a good effervescent reaction and minimized issues with capping and sticking.

Cite this article:
Dr. Majid S. Khan, Devendra Bagul, Sakshi Bachhav, Nishigandha Bagul, Sumit Birari, Siddharth Batole, Dr. Avish Maru. Herbal-Based Fennel-Flavored Effervescent Tablets: A Novel Approach to Natural GI Health. IJRPAS, June 2025; 4 (6): 86-95.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.4609


1.      Kumar et al. (2020). Development and Evaluation of Effervescent Tablets Containing Ajwain and Fennel. Journal of Pharmaceutical Sciences, 109(3), 1231-1238.

2.      The United States Pharmacopeia (USP). Effervescent Tablets. USP Convention. 2020.

3.      Cooper, J. W. (2017). Pharmaceutical and Medicinal Chemistry. 2nd ed. CRC Press.

4.      Aulton, M. E. (2017). Aulton's Pharmaceutics: The Design and Manufacture of Medicines. 5th ed. Elsevier

5.      Felton, L. A. (2019). Remington: Essentials of Pharmaceutics. 2nd ed. Pharmaceutical Press.

6.      Evans, W. C. (2009). Trease and Evans' Pharmacognosy. 16th ed. Elsevier.

7.      Quality Control and Assurance in Herbal Pharmaceuticals. World Health Organization. 2011.

8.      ASM Handbook, Volume 8: Mechanical Testing and Evaluation. ASM International. 2000.

9.      USP <616> Bulk Density and Tapped Density of Powders. United States Pharmacopeia. 2020.

10.  ASTM D6393-14: Standard Test Method for Bulk Solids Characterization by Carr Indices. ASTM International. 2014

11.  Carr, R. L. (1965). Evaluating flow properties of solids. Chemical Engineering, 72(2), 163-168.

12.  Hausner, H. H. (1967). Friction conditions in a mass of metal powder. International Journal ofPowder Metallurgy, 3(2), 7-13

13.  United States Pharmacopeia (USP) <1217> Tablet Breaking Force. USP Convention. 2020.

14.  USP <1217> Tablet Breaking Force. USP Convention. 2020.

15.  USP <905> Uniformity of Dosage Units. USP Convention. 2020.

16.  USP <1216> Tablet Friability. USP Convention. 2020.

17.  European Pharmacopoeia 10.0, 2.9.35. Effervescent tablets. European Directorate for the Quality of Medicines. 2020.

18.  Spectrophotometry in the UV and Visible Region. International Union of Pure and Applied Chemistry (IUPAC). 2014.

19.  USP <791> pH. USP Convention. 2020.

20.  Indian Pharmacopoeia (IP). Assay of Herbal Granules. Indian Pharmacopoeia Commission. 2018.

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags